On Tuesday the state Duma approved the second reading of the bill on which the government can point to delay the introduction of mandatory labelling for a number of drugs and medical products. It is a compromise between the need to start the system marks the previously established deadline of July 1, 2020, and the possible risks of certain problems with the labeling of the pandemic coronavirus— their fears a number of partorganizatsii. According to the health Ministry, to launch mandatory labeling next week ready all companies, the measure will affect the minimum number of drugs and will act temporarily in the form of a deferral. Exceptions will require individual solutions the White house after the explanation of company-specific reasons why it cannot release the drug to the market standard for all fine.The government can make an exception for compulsory labeling for some drugs and medical devices — the state Duma has approved corresponding amendments. They were made for the second reading of the bill to create a Federal registry of citizens entitled to the provision of drugs.We will remind, since July 1 this year, marking drugs will become mandatory. A number of medical associations and unions of the patients asked the government to delay the implementation of the system for a few months, fearing that some of the products may not be available for the Russian market (see “Kommersant” on April 9).As explained in the press service of the Ministry of health permits for the importation and putting into civil circulation of unmarked medications will only be issued in exceptional cases, manufacturers will have to justify the reasons for non-compliance of mandatory labeling. “Russian and foreign manufacturers on time prepared for the introduction of mandatory labelling, so this measure is in the nature of additional, and we do not expect difficulties with the supply of drugs”,— told in the Ministry of health.On readiness of all participants to the labelling of medicines and informs a healthcare. On Tuesday, the Agency summarized the results of system testing, which took place from 1 to 11 June. It was attended by more than 300 organizations from 65 regions — is the largest pharmaceutical distributors, medical and pharmacy organizations, and individual entrepreneurs.However, as noted by the first Deputy head of the Duma Committee on health protection Leonid Ogul, although in principle the system is ready to work, because of the pandemic and the consequent shutdown of many industrial and economic processes, it was decided not to risk and to give the government the ability to maneuver. “This two-tier system will assess the current situation and to take targeted solutions to the government, if they are necessary”,— said the head of the Duma Committee on Oh��Ana health Dmitry Morozov.Anastasia Manuylova
